JCI table of contents: Dec. 3, 2007 (ary the results of this work point to th...)

JCI table of contents: Dec. 3, 2007

Date:12/3/2007

ary, the results of this work point to the interaction between OX40 and its partner protein, OX40L, as a promising therapeutic target for the treatment of allergic diseases.

In the study, blocking OX40/OX40L interactions reduced allergic responses in mice with TSLP-induced inflammation of the lungs or skin and in mice with chronic or acute asthma. In addition, the same approach reduced allergic responses in monkeys with dust-mite induced allergic asthma. The reduction in the severity of the allergic response was associated with a decrease in the generation of inflammatory cells and proteins, as well as the production of immune cells.

TITLE: In vivo blockade of OX40 ligand inhibits thymic stromal lymphopoietin driven atopic inflammation

AUTHOR CONTACT:
Flavius Martin
Genentech Inc., South San Francisco, California, USA
Phone: (650) 225-2731; Fax: (650) 225-8221; E-mail: flavius@gene.com.

View the PDF of this article at: https://www.the-jci.org/article.php?id=33559

ACCOMPANYING COMMENTARY
TITLE: OX40-OX40L interactions: a promising therapeutic target for allergic diseases?

AUTHOR CONTACT:
Yong-Jun Liu
The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
Phone: (713) 563-3203; Fax: (713) 563-3275; E-mail: yjliu@mdanderson.org

Yui-Hsi Wang
The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
Phone: (713) 563-3306; Fax: (713) 563-3275; E-mail: yuiwang@mdanderson.org

View the PDF of this article at: https://www.the-jci.org/article.php?id=34182

AUTOIMMUNITY: Treating type 1 diabetes by eliminating B cells

Autoimmune diseases such as type 1 diabe
'/>"/>

Contact: Karen Honey
press_releases@the-jci.org
215-573-1850
Journal of Clinical Investigation
Source:Eurekalert

2

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13
Related biology technology :

1. Ranexa(R) Added to New ACC/AHA Guidelines on Unstable Angina/Non ST-Elevation Myocardial Infarction (UA/NSTEMI)
2. AUDIO from Medialink and GlaxoSmithKline: Fiber Key in Managing Irritable Bowel Syndrome (IBS) Symptoms
3. Lexicon Presents Class of Compounds Modulating TPH1, the Target for its LX1031 Investigational Drug for Irritable Bowel Syndrome
4. FDA Accepts Sucampos sNDA for Lubiprostone (8 mcg) for the Treatment of Irritable Bowel Syndrome with Constipation (IBS-C)
5. Sheet of carbon atoms acts like a billiard table, physicists find
6. Sheet of carbon atoms acts like a billiard table, physicists find
7. New Phase III Data Demonstrate Oxycodone / Naloxone Combination Tablet Reduces Opioid-Induced Bowel Dysfunction in Patients With Chronic Severe Pain
8. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Methimazole Tablets USP, 5 mg and 10 mg
9. Dey L.P. and Critical Therapeutics Launch Twice-Daily ZYFLO CR(TM) (Zileuton) Extended-Release Tablets for the Chronic Treatment of Asthma
10. FDA Approves New 300mg Loading Dose Tablet for PLAVIX(R) (clopidogrel bisulfate)
11. CV Therapeutics Submits Supplemental New Drug Application for Ranexa(R) (ranolazine extended-release tablets)

Post Your Comments:

(Date:12/16/2009)... Soy Peptone. HSP A has been found to be effectinve ... ... December 16, 2009 -- Nu-Tek BioSciences, LLC. ( www.nu-tekproducts.com ) is ... HSP-A, previously manufactured by Nutricepts, Inc. (Burnsville, Mn), is a ... rates and yields. HSP-A has been found to be especially ...

(Date:12/15/2009)... Joint BioEnergy Institute (JBEI), one of three Department of ... trusted time-stamping service to protect its valuable intellectual property. ... ... VA (PRWEB) December 15, 2009 -- Surety, LLC ... solutions , today announced that the Joint BioEnergy Institute ...

(Date:12/15/2009)... -- Reportlinker.com announces that a new market ... ,, The Future of Orphan ... Pipeline Analysis and Reimbursement ,, ... Summary ,, The author has ... Orphan Diseases Therapeutics - Market Forecasts to ...

(Date:12/15/2009)... NeedleProbes™ for Atomic Force Microscopy (AFM) have been developed ... studies at the liquid/air interface. The NeedleProbes’ cylindrical geometry ... evaporation rate and viscosity - all in a single force ... ... 15, 2009 -- New, constant diameter NeedleProbes are ...

[0] Nu-Tek BioSciences, LLC. Launches Animal-Free, Non-GM Soy Peptone [0] Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property [0] Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement [0] New Constant Diameter NeedleProbes™ with Unique Ability to Measure Liquid Surface Properties by AFM

... long ago as 1988, I enthusiastically embraced the idea that ... create magazines to examine and celebrate that life. Both times, ... time. , ,Now, many years later, I'm getting very excited ... digital lifestyle. This time, though, the market conditions are fundamentally ...

... Third Wave Technologies has announced the launch ... In conjunction with Invaders premiere, the company announced a ... non-profit health plan in the United States, to supply ... customer, said Rod Hise, director, corporate communications of Third ...

... ideas and small microchips. , ,In dictionary terms, it ... and high technology. In real-life terms, it means that I ... end up in my basement aside X.10 cameras, a commercial-strength ... video games and a pile of last years gadgets de ...

Other Biology Technology:Digital Lifestyle: I'm linked in, now what? 2 Digital Lifestyle: I'm linked in, now what? 3 Digital Lifestyle: I'm linked in, now what? 4 Third Wave strikes deal with Kaiser Permanente on cystic fibrosis reagents 2 Three mainstream technologies you should not ignore 2

Digital Lifestyle: I'm linked in, now what?Third Wave strikes deal with Kaiser Permanente on cystic fibrosis reagents Three mainstream technologies you should not ignore

(Date:12/16/2009)... LONDON, Dec. 16 European Union ... protecting their borders, which are increasingly subjected ... High investment in advanced technology security and ... market. ,, (Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO ) ,, ... http://www.aerospace.frost.com ), Border Security Market Assessment ...

(Date:12/15/2009)... COLUMBIA, Mo. As soon as babies are ... as jaundice and e-coli. For up to a month, ... Although these infections are often minor, they can lead ... newborns, immune systems, University of Missouri researchers have pinpointed ... lead to an immune-strengthening vaccine. , "We,re trying to ...

(Date:12/15/2009)... agreement with the British Society for Research on Ageing ... Biogerontology for an initial period of three ... the Biogerontology editorial board and will acquire ... sponsor the society and provide society members with free ... . , Biogerontology offers a platform for ...

Breaking Biology News(10 mins):Increased Spending on the EU's External Borders to Drive the Border Security Market, Says Frost & Sullivan 2 Increased Spending on the EU's External Borders to Drive the Border Security Market, Says Frost & Sullivan 3 Researchers work on vaccine to improve immune system in newborns 2 Sizable Health Disparities Evident in Every State Between Women of Different Racial and Ethnic Groups 48394 1 Sizable Health Disparities Evident in Every State Between Women of Different Racial and Ethnic Groups 48394 2 Sizable Health Disparities Evident in Every State Between Women of Different Racial and Ethnic Groups 48394 3 University of Texas Picosatellite to be launched from space shuttle to begin milestone mission 12548 1 University of Texas Picosatellite to be launched from space shuttle to begin milestone mission 12548 2 University of Texas Picosatellite to be launched from space shuttle to begin milestone mission 12548 3 Two Year Data Show Patients Receiving SIMPONI 28TM 29 28golimumab 29 Experienced Sustained Improvement in Signs and Symptoms of Psoriatic Arthritis a 4578 1 Two Year Data Show Patients Receiving SIMPONI 28TM 29 28golimumab 29 Experienced Sustained Improvement in Signs and Symptoms of Psoriatic Arthritis a 4578 2 Two Year Data Show Patients Receiving SIMPONI 28TM 29 28golimumab 29 Experienced Sustained Improvement in Signs and Symptoms of Psoriatic Arthritis a 4578 3 Two Year Data Show Patients Receiving SIMPONI 28TM 29 28golimumab 29 Experienced Sustained Improvement in Signs and Symptoms of Psoriatic Arthritis a 4578 4 Two Year Data Show Patients Receiving SIMPONI 28TM 29 28golimumab 29 Experienced Sustained Improvement in Signs and Symptoms of Psoriatic Arthritis a 4578 5 Two Year Data Show Patients Receiving SIMPONI 28TM 29 28golimumab 29 Experienced Sustained Improvement in Signs and Symptoms of Psoriatic Arthritis a 4578 6 Two Year Data Show Patients Receiving SIMPONI 28TM 29 28golimumab 29 Experienced Sustained Improvement in Signs and Symptoms of Psoriatic Arthritis a 4578 7 Two Year Data Show Patients Receiving SIMPONI 28TM 29 28golimumab 29 Experienced Sustained Improvement in Signs and Symptoms of Psoriatic Arthritis a 4578 8 Two Year Data Show Patients Receiving SIMPONI 28TM 29 28golimumab 29 Experienced Sustained Improvement in Signs and Symptoms of Psoriatic Arthritis a 4578 9 Two Year Data Show Patients Receiving SIMPONI 28TM 29 28golimumab 29 Experienced Sustained Improvement in Signs and Symptoms of Psoriatic Arthritis a 4578 10 Two Year Data Show Patients Receiving SIMPONI 28TM 29 28golimumab 29 Experienced Sustained Improvement in Signs and Symptoms of Psoriatic Arthritis a 4578 11 Two Year Data Show Patients Receiving SIMPONI 28TM 29 28golimumab 29 Experienced Sustained Improvement in Signs and Symptoms of Psoriatic Arthritis a 4578 12

[0] Increased Spending on the EU's External Borders to Drive the Border Security Market, Says Frost & Sullivan [0] Researchers work on vaccine to improve immune system in newborns [0] Springer signs agreement with British Society of Research on Ageing

... As the Arctic Ocean warms this century, shellfish, snails ... an invasion of the northern Atlantic that was interrupted ... Vermeij, professor of geology at the University of California, ... Sciences. , Climate models predict a nearly ice-free Arctic ...

... University of Texas Health Science Center at Houston have ... to determine whether gluten and dairy products play a ... The pilot study is one of seven current studies ... Department of Psychiatry and Behavioral Sciences at The University ...

... 07 August 2008 - "Big things come in ... more true when discussing the mouse. This little ... through its contributions in understanding human genetics and disease. ... (DMM), http://dmm.biologists.org , genetics researchers from Yale University ...

Other Biology News:Pacific shellfish ready to invade Atlantic 2 UT Health Science Center researchers study diet and autism 2

Pacific shellfish ready to invade Atlantic UT Health Science Center researchers study diet and autism Anything but modest: The mouse continues to contribute to humankind

ICAD / DFF45 (NT) Affinity Purified Polyclonal Antibody...

Anti-Human IFN-Gamma Receptor Chain 2 (beta chain) [CD119], Rabbit serum, NON-neutralizing polyclonal antibody...

Anti-BAR Immunogen: Peptide of aa 3-21 from human Bar Available Date: 38226...

... the HECT protein, E6-AP and ... suggests that this E2 is ... of non-""N-end rule"" protein substrates ... proteins as well as the ...

Biology Products:

Rabbit Anti-ICAD / DFF45 (NT) Polyclonal Antibody, Unconjugated from ProSci, Inc Rabbit Anti-Human IFN-Gamma Receptor Chain 2 (beta chain) [CD119] NON-neutralizing Polyclonal Antibody, Unconjugated from Cell Sciences Rabbit Anti-Human BAR Antibody, Unconjugated from CHEMICON Anti-UbcH7 Antibody, Unconjugated from CHEMICON

JCI table of contents: Dec. 3, 2007(ary the results of this work point to th...)